N. Rodríguez

Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.

A. Lage, M. Stabin, N. Iznaga-Escobar, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

BIODISTRIBUTION AND DOSIMETRY OF 99 m Tc-LABELED MONOCLONAL ANTIBODY ior egf / r 3 IN PATIENTS WITH TUMORS OF EPITHELIAL ORIGIN : PRELIMINARY RESULTS

M. Stabin, N. Iznaga-Escobar, M. Ramos, 2022 .

Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma.

W. Meyers, R. Sandler, M. Lan, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor.

A. Lage, T. Crombet, M. Catalá, 2001, Cancer biotherapy & radiopharmaceuticals.

ior egf/r3: A murine monoclonal antibody for diagnostic of epithelial tumors

T. Rodríguez, M. R. Suzarte, A. Morales, 1999 .

99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy.

M. Ramos-Suzarte, N. Iznaga-Escobar, R. Pérez, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.